Literature DB >> 8144788

Ebstein's anomaly: outcome of pregnancy.

H M Connolly1, C A Warnes.   

Abstract

OBJECTIVES: The outcome of pregnancy in Ebstein's anomaly was studied in 72 such patients (44 women, 28 men) who had had pregnancies or fathered children.
BACKGROUND: Patients with Ebstein's anomaly often reach childbearing age. Reports of the outcome of pregnancy in Ebstein's anomaly are available; however, the number of patients is small.
METHODS: The medical and surgical data bases at the Mayo Clinic were reviewed, and 145 patients (62 men, 83 women) of childbearing age with Ebstein's anomaly were located. All patients were contacted, and 72 patients (44 women, 28 men) with offspring were identified and reviewed in detail to assess the outcome of pregnancy.
RESULTS: Forty-four women had 111 pregnancies resulting in 85 live births (76%). Seventy-six deliveries (89%) were vaginal, and nine (11%) were by cesarean section. Twenty-three deliveries were premature. There were 19 spontaneously unsuccessful pregnancies, 7 therapeutic abortions and 2 early neonatal deaths. The mean birth weight of the infants born to cyanotic women was 2.53 kg, which was significantly lower than the mean birth weight of infants born to acyanotic women (3.14 kg [p < 0.001]). The overall incidence of congenital heart disease in the 158 offspring of parents with Ebstein's anomaly was 4% (6 of 158). The incidence of congenital heart disease was 6% (5 of 83) in the offspring of women with Ebstein's anomaly and 1% (1 of 75) in that of men. There was a 0.6% (1 of 158) incidence of familial Ebstein's anomaly. There were no serious pregnancy-related maternal complications, which included maternal death, stroke, congestive heart failure, arrhythmias or endocarditis.
CONCLUSIONS: Pregnancy in women with Ebstein's anomaly is well tolerated. It is associated with an increased risk of prematurity, fetal loss and congenital heart disease in the offspring. In addition, a significantly lower birth weight is found in the offspring of cyanotic versus acyanotic women with Ebstein's anomaly. Paternal Ebstein's anomaly also seems to result in an increased risk of congenital heart disease in the offspring compared with the incidence in the general population.

Entities:  

Mesh:

Year:  1994        PMID: 8144788     DOI: 10.1016/0735-1097(94)90610-6

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  16 in total

1.  Cardiοvascular diseases in pregnancy.

Authors:  Dimitrios Godosis; Spyridon Komaitis; Konstantinos Tziomalos; Maria Baltatzi; Georgios Ntaios; Christos G Savopoulos; Apostolos I Hatzitolios
Journal:  Am J Cardiovasc Dis       Date:  2012-05-15

Review 2.  Congenital and Acquired Valvular Heart Disease in Pregnancy.

Authors:  Sarah A Goldstein; Cary C Ward
Journal:  Curr Cardiol Rep       Date:  2017-08-24       Impact factor: 2.931

3.  Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfan's syndrome.

Authors:  Candice K Silversides; Marla Kiess; Luc Beauchesne; Timothy Bradley; Michael Connelly; Koichiro Niwa; Barbara Mulder; Gary Webb; Jack Colman; Judith Therrien
Journal:  Can J Cardiol       Date:  2010-03       Impact factor: 5.223

Review 4.  Pregnancy in Women with Congenital Heart Disease.

Authors:  Evin Yucel; Doreen DeFaria Yeh
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-08-22

Review 5.  Role of echocardiography in the assessment and management of adult congenital heart disease in pregnancy.

Authors:  Antonio Vitarelli; Lidia Capotosto
Journal:  Int J Cardiovasc Imaging       Date:  2010-11-17       Impact factor: 2.357

6.  Pregnancy in young women with congenital heart disease: Lesion-specific considerations.

Authors:  Rachel M Wald; Mathew Sermer; Jack M Colman
Journal:  Paediatr Child Health       Date:  2011-05       Impact factor: 2.253

Review 7.  Pregnancy in women with congenital heart disease.

Authors:  Heidi M Connolly
Journal:  Curr Cardiol Rep       Date:  2005-07       Impact factor: 2.931

8.  Management of Pregnancy in Women With Repaired CHD or After the Fontan Procedure.

Authors:  Reema Chugh
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-10

Review 9.  Valvular Heart Disease in Pregnancy.

Authors:  Jennifer Lewey; Lauren Andrade; Lisa D Levine
Journal:  Cardiol Clin       Date:  2020-11-02       Impact factor: 2.213

10.  Management of pregnancy in women with palliated and unpalliated congenital heart defects.

Authors:  Reema Chugh
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.